Investing.com - TRACON Pharma (NASDAQ: TCON) reported first quarter EPS of $-0.010, $0.07 better than the analyst estimate of $-0.080. Revenue for the quarter came in at $3.05M versus the consensus estimate of $1.5M.
TRACON Pharma's stock price closed at $0.190. It is up 0.900% in the last 3 months and down -87.380% in the last 12 months.
TRACON Pharma saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See TRACON Pharma's stock price’s past reactions to earnings here.
According to InvestingPro, TRACON Pharma's Financial Health score is "fair performance".
Check out TRACON Pharma's recent earnings performance, and TRACON Pharma's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar